Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait

Author:

Cai Yanwei1ORCID,Franceschini Nora2,Surapaneni Aditya34ORCID,Garrett Melanie E.5ORCID,Tahir Usman A.67,Hsu Li1ORCID,Telen Marilyn J.58ORCID,Yu Bing9ORCID,Tang Hua10,Li Yun11ORCID,Liu Simin12ORCID,Gerszten Robert E.67ORCID,Coresh Josef34ORCID,Manson JoAnn E.13ORCID,Wojcik Genevieve L.3ORCID,Kooperberg Charles2,Auer Paul L.14ORCID,Foster Matthew W.15ORCID,Grams Morgan E.16ORCID,Ashley-Koch Allison E.5ORCID,Raffield Laura M.11ORCID,Reiner Alex P.117

Affiliation:

1. Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington

2. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina

3. Department of Epidemiology and Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

4. Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

5. Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina

6. Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts

7. Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts

8. Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina

9. School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas

10. Department of Genetics, Stanford University School of Medicine, Stanford, California

11. Department of Genetics, University of North Carolina, Chapel Hill, North Carolina

12. Center for Global Cardiometabolic Health, Departments of Epidemiology, Medicine, and Surgery, Brown University, Providence, Rhode Island

13. Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

14. Division of Biostatistics, Institute for Health and Equity, and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin

15. Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University Medical Center, Durham, North Carolina

16. Division of Precision Medicine, New York University Grossman School of Medicine, New York, New York

17. Department of Epidemiology, University of Washington, Seattle, Washington

Abstract

Background Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait. Methods We measured proteomics (N=1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait. Results In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait–protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait–associated proteins are known biomarkers of kidney function or injury (e.g., hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and α-hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait–associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58). Conclusions We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.

Funder

NIDDK

National Human Genome Research Institute

National Institute on Minority Health and Health Disparities

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Nontargeted Plasma Proteomic Analysis of Renal Disease and Pulmonary Hypertension in Patients with Sickle Cell Disease;Journal of Proteome Research;2024-02-14

2. Sickle Cell Trait and Circulating Proteome;Clinical Journal of the American Society of Nephrology;2023-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3